Biotechnology Industry Organization (BIO)

Release Summary

The bill introduced today does not contain any of the critically needed reforms to prevent the continued exploitation and abuse of the PTO’s inter partes review (IPR) proceeding against patent owners

Biotechnology Industry Organization (BIO)